Coca-Cola HBC AG

Director's Dealing • Dec 22, 2025

National Storage Mechanism | Additional information

RNS Number : 5300M

Coca-Cola HBC AG

22 December 2025

FOR IMMEDIATE RELEASE

22 December 2025

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company has been notified that the following PDMR sold ordinary shares of CHF 6.70 each in the Company on 19 December 2025.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

MINAS AGELIDIS

2

Reason for the notification

a)

Position/status

REGIONAL DIRECTOR

b)

Initial notification /Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

COCA-COLA HBC AG

b)

LEI

549300EFP3TNG7JGVE49

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

CH0198251305

b)

Nature of the transaction

SALE OF 8,000 SHARES UNDER EMPLOYEE STOCK PURCHASE PLAN AT GBP 38.016025 PER SHARE, RESULTING IN THE NET AMOUNT OF APPROX GBP 303,139.78

c)

Price(s) and volume(s)

Price(s)	Volume(s)
38.016025 GBP	8,000

d)

Aggregated information

- Aggregated volume

- Price

Price	Volume	Total
38.016025 GBP	8,000	304,128.20 GBP

e)

Date of the transaction

2025-12-19

f)

Place of the transaction

XLON

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHPKBBNNBDDCBB